ACTRN12619000174189Not yet recruiting未知
Exercise as medicine for heart failure: A novel intervention to improve outcomes
The University of western Australia0 sites100 target enrollmentStarted: February 6, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •NYHA Class II-IIIb with systolic dysfunction (HFrEF, EF <40%).
- •Willing and able to sign written informed consent prior to trial entry
- •Suitable to participate in a 16-week exercise training program, as determined by the medical history and physical examination
Exclusion Criteria
- •Current smoking or smoking in the past 12 months,
- •Renal impairment (stage 4 or 5 CKD),
- •Exercise-induced ischaemia at a low workload (<3 METS),
- •Hypertension (>165/95mmHg)
- •Diagnosed peripheral artery disease
Investigators
Similar Trials
Completed
Not Applicable
Acute effects of exercise in heart failure - a pilot studydecompensatio cordisheart decompensation10019280heart failureNL-OMON37247Fysiologie45
Not yet recruiting
Not Applicable
Heart failure and Promotion of Physical Activity before and after Cardiac reHabilitatiocardiac failure10019280heart failureNL-OMON49839Erasmus MC, Universitair Medisch Centrum Rotterdam180
Not yet recruiting
Not Applicable
Heart Failure and Promotion of Physical Activity before and after Cardiac reHabilitatioNL-OMON24242Erasmus Medical Center180
Recruiting
Not Applicable
Acute effects of exercise in heart failure: A pilot study.heart failure, exercise training, vascular shear ratehartfalen, inspanning, training, bloedflow patronenNL-OMON24144Radboud University Nijmegen Medical Centre30
Completed
Not Applicable
The development of the treatment for heart failure using non-pulsatile Left ventricle assist deviceEnd-staged dilated cardiomyopathy and ischemic cardiomyopathy who receive Left ventricle assist deviseJPRN-UMIN000003665Medical Center for Translational Research, Osaka University Hospital10